Press release
Spatial Genomics and Transcriptomics Market Worth $800 Million by 2027 - Leading Key Players are NanoString Technologies, Inc. (US), 10X Genomics (US), Illumina (US), Bio-Rad Laboratories (US), Bio-Techne Corporation (US), Standard BioTools Inc. (US)
Spatial Genomics and Transcriptomics Market Worth $800 Million by 2027
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=170900551&utm_source=OPenpr&utm_medium=referral&utm_campaign=paidpr
Browse in-depth TOC on "Spatial Genomics and Transcriptomics Market"
266 - Tables
41 - Figures
233 - Pages
Spatial Transcriptomics techniques accounted for the largest share of the spatial genomics & transcriptomics market
Based on the technique, the spatial genomics and transcriptomics market is segmented into spatial transcriptomics techniques and spatial genomics analysis techniques. In 2021, the spatial transcriptomics techniques segment accounted for the largest share of the global spatial genomics and transcriptomics market. Growth in this market segment can be attributed to the high adoption of spatial transcriptomics in drug discovery and development, introduction of novel products, increasing R&D investments and public-private funding.
Consumables is the largest-growing product segment of the spatial genomics & transcriptomics market
Based on product, the spatial genomics and transcriptomics market is segmented into consumables, instruments, and software. In 2021, the consumables segment accounted for the largest share of the product segment of spatial genomics and transcriptomics market. Market growth can largely be attributed to the growing applications of spatial genomics and transcriptomics in drug discovery & development and biomarker identification and the growing use of consumables.
North America accounted for the largest share of the spatial genomics & transcriptomics market
North America held the largest share in the global market, followed by Europe. The large share of the North American regional segment can be attributed to the rising focus on drug discovery & development, attributed to the growing incidence of chronic diseases and genetic diseases and the rapidly growing aging population, also supports the use of spatial genomics and transcriptomics operating in the spatial genomics and transcriptomics market in this region.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=170900551&utm_source=OPenpr&utm_medium=referral&utm_campaign=paidpr
Spatial Genomics and Transcriptomics Market Dynamics:
Drivers:
Increasing adoption of spatial genomics & transcriptomics in drug discovery & development
Introduction of novel products
Increasing R&D investments and public-private funding
Restraints:
High capital investments
Opportunities:
Increasing use of spatial omics for biomarker identification
Challenges:
Dearth of skilled professionals
Key Market Players:
The spatial genomics & transcriptomics market is consolidated in nature with prominent players in the spatial genomics & transcriptomics market include NanoString Technologies, Inc. (US), 10X Genomics (US), Illumina (US), Bio-Rad Laboratories (US), Bio-Techne Corporation (US), Standard BioTools Inc. (US), Genomic Vision SA (France), Akoya Biosciences, Inc. (US), Danaher Corporation (US), Natera, Inc. (US), PerkinElmer, Inc. (US), Seven Bridges Genomics (US), S2 Genomics, Inc. (US), Cantata Bio (US), Vizgen Corporation (US), BioSpyder Technologies Inc. (US), Optical Biosystems Inc. (US), Miltenyi Biotec (Germany), Ultivue Inc. (US), Lunaphore Technologies SA (Switzerland), Rebus Biosystems LLC (US), Resolve Biosciences (Germany), Singular Genomics, Inc. (US), and Veracyte (US).
Recent Developments:
In 2022, NanoString and Abcam announced an agreement to co-market Abcam antibodies for NanoString's high-plex spatial multiomics solutions.
In 2022, 10x Genomics announced the first commercial shipments of its Xenium platform for in situ analysis. Xenium is the next generation of targeted spatial profiling of genes and proteins at subcellular resolution.
In 2022, Illumina and AstraZeneca announced a strategic research collaboration to accelerate drug target discovery by combining their strengths in AI-based genome interpretation and genomic analysis techniques with industry expertise.
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=170900551&utm_source=OPenpr&utm_medium=referral&utm_campaign=paidpr
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
About MarketsandMarkets™:
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Spatial Genomics and Transcriptomics Market Worth $800 Million by 2027 - Leading Key Players are NanoString Technologies, Inc. (US), 10X Genomics (US), Illumina (US), Bio-Rad Laboratories (US), Bio-Techne Corporation (US), Standard BioTools Inc. (US) here
News-ID: 2887737 • Views: …
More Releases from MarketsandMakets
Wire & Cable Market worth $266.2 billion by 2029
The report "Wire & Cable Market by Product Type (Electronic Wire, Power Cable, Control & Instrumentation Cable, Communication Cable, Flexible & Specialty Cable), Material Type, Voltage, Installation, End-Use Industry, and Region - Global Forecast to 2029", wire & cable market is estimated at USD 201.0 billion in 2024 and is projected to reach USD 266.2 billion by 2029, at a CAGR of 5.8% from 2024 to 2029.
Browse in-depth TOC on…
Future of Healthcare Biometrics Market: Development, Industry Size, Key Players, …
Biometrics as a Service in Healthcare Market in terms of revenue was estimated to be worth $0.4 billion in 2023 and is poised to reach $1.1 billion by 2028, growing at a CAGR of 20.7% from 2023 to 2028 according to a new report by MarketsandMarkets™.
The amalgamation of biometric data with cutting-edge analytics and artificial intelligence (AI) has emerged as a transformative force within the healthcare sector, significantly bolstering market…
Clinical Communication & Collaboration Market Worth $4.8 billion | MarketsandMar …
Clinical Communication & Collaboration Market in terms of revenue was estimated to be worth $2.6 billion in 2024 and is poised to reach $4.8 billion by 2029, growing at a CAGR of 13.2% from 2024 to 2029 according to a new report by MarketsandMarkets™.
The growth in the clinical communication and collaboration market is driven by high prevalence of chronic diseases, rising prominence of big data and mHelath tools, and stringent…
Exploring Market Surge: Impact of Booming Computer Vision Healthcare Market on I …
Computer Vision in Healthcare Market in terms of revenue was estimated to be worth $3.9 billion in 2024 and is poised to reach $11.5 billion by 2029, growing at a CAGR of 24.0% from 2024 to 2029 according to a new report by MarketsandMarkets™.
The market's expansion is fueled by the exponential growth of medical imaging data which necessitates efficient analysis methods, where computer vision techniques excel in automating and enhancing…
More Releases for Genomic
Emerging Trends Influencing The Growth Of The Genomic Biomarker Market: Technolo …
The Genomic Biomarker Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
How Big Is the Genomic Biomarker Market Size Expected to Be by 2034?
The size of the genomic biomarker market has witnessed swift expansion in the recent past. It is slated to expand from a…
Top Factor Driving Genomic Biomarker Market Growth in 2025: Impact of Chronic Di …
How Big Is the Genomic Biomarker Market Expected to Be, and What Will Its Growth Rate Be?
The size of the genomic biomarker market has seen a swift expansion in recent times. It's expected to increase from $8.4 billion in 2024 to $9.9 billion in 2025, growing at a compound annual growth rate (CAGR) of 18.0%. The historic period growth can be credited to the growing awareness about genetic disorders, heightened…
Genomic Biomarker Market Future Business Opportunities 2025-2032 | Liquid Genomi …
Latest Report, titled "Genomic Biomarker Market" Trends, Share, Size, Growth, Opportunity and Forecast 2025-2032, by Coherent Market Insights offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
The report features a comprehensive table of contents, figures, tables, and charts, as well as insightful analysis. The Genomic Biomarker market has been expanding significantly…
Lipid-Nanoparticle Based Genomic Medicines Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Lipid-Nanoparticle Based Genomic Medicines Market - (By Type (Liposome-based Nanoparticles, Micelle-based Nanoparticles, Lipid-Coated Nanoparticles), By Application (Cancer Treatment, Infectious Diseases, Genetic Disorders, Cardiovascular Diseases, Others), By Therapeutic Payload (mRNA-based Therapeutics, siRNA-based Therapeutics, miRNA-based Therapeutics, Other Genomic Medicines), By End-User (Hospitals, Biopharmaceutical Companies, Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the…
Genomic Biomarkers Market 2022 | Detailed Report
The research reports on “Genomic Biomarkers Market” report gives detailed overview of factors that affect global business scope. Genomic Biomarkers Market report shows the latest market insights with upcoming trends and breakdowns of products and services. This report provides statistics on the market situation, size, regions and growth factors. An exclusive data offered in this report is collected by research and industry experts team.
Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5334064
The…
Latest Survey on Genomic Medicine Market 2019 by Key Companies Overview-BioMed C …
The recently published report called “Global Genomic Medicine Market 2019” offers a brief overview of the Genomic Medicine market across the globe. The research report showcases innovative tool for evaluating the complete scenario of the Genomic Medicine market with its tactical decision making, opportunities and supporting strategic. Furthermore, the report also analyses the competitive analysis as well as changing trends which becomes most crucial in order to monitor the performance…
